Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.668, 2012-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Musculoskeletal disorders: substantial economic burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 323, 2001-01 ,pp. :
Access to resources
Recommend
Oral linezolid cost saving in MRSA-related infections
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
Alcoholism burden substantial in Scotland
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 385, 2002-01 ,pp. :
The Health-Related Quality of Life and Economic Burden of Constipation
PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. :
MS poses substantial employer burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 588, 2009-01 ,pp. :